This meta-analysis evaluates the efficacy and safety of mesenchymal stem cells (MSCs) for the treatment of Crohn’s disease. It summarizes the findings from multiple clinical trials and provides a comprehensive assessment of the potential benefits and risks of MSC therapy.
Menu
